116 related articles for article (PubMed ID: 35007512)
1. A two-sex model of human papillomavirus infection: Vaccination strategies and a case study.
Gao S; Martcheva M; Miao H; Rong L
J Theor Biol; 2022 Mar; 536():111006. PubMed ID: 35007512
[TBL] [Abstract][Full Text] [Related]
2. A Dynamic Model to Assess Human Papillomavirus Vaccination Strategies in a Heterosexual Population Combined with Men Who have Sex with Men.
Gao S; Martcheva M; Miao H; Rong L
Bull Math Biol; 2021 Jan; 83(1):5. PubMed ID: 33387083
[TBL] [Abstract][Full Text] [Related]
3. The impact of vaccination on human papillomavirus infection with disassortative geographical mixing: a two-patch modeling study.
Gao S; Martcheva M; Miao H; Rong L
J Math Biol; 2022 Apr; 84(6):43. PubMed ID: 35482215
[TBL] [Abstract][Full Text] [Related]
4. Modelling the population-level impact of vaccination on the transmission of human papillomavirus type 16 in Australia.
Regan DG; Philp DJ; Hocking JS; Law MG
Sex Health; 2007 Sep; 4(3):147-63. PubMed ID: 17931528
[TBL] [Abstract][Full Text] [Related]
5. Sex-specific immunization for sexually transmitted infections such as human papillomavirus: insights from mathematical models.
Bogaards JA; Kretzschmar M; Xiridou M; Meijer CJ; Berkhof J; Wallinga J
PLoS Med; 2011 Dec; 8(12):e1001147. PubMed ID: 22205887
[TBL] [Abstract][Full Text] [Related]
6. Low prevalence of vaccine-type HPV infections in young women following the implementation of a school-based and catch-up vaccination in Quebec, Canada.
Goggin P; Sauvageau C; Gilca V; Defay F; Lambert G; Mathieu-C S; Guenoun J; Comète E; Coutlée F
Hum Vaccin Immunother; 2018 Jan; 14(1):118-123. PubMed ID: 29049007
[TBL] [Abstract][Full Text] [Related]
7. Human Papillomavirus Infection and Vaccination.
Valentino K; Poronsky CB
J Pediatr Nurs; 2016; 31(2):e155-66. PubMed ID: 26586310
[TBL] [Abstract][Full Text] [Related]
8. Facilitators and barriers of human papillomavirus vaccine uptake in young females 18-26 years old in Singapore: A qualitative study.
Lim ASE; Lim RBT
Vaccine; 2019 Sep; 37(41):6030-6038. PubMed ID: 31473002
[TBL] [Abstract][Full Text] [Related]
9. Prevention of HPV-related cancers in Norway: cost-effectiveness of expanding the HPV vaccination program to include pre-adolescent boys.
Burger EA; Sy S; Nygård M; Kristiansen IS; Kim JJ
PLoS One; 2014; 9(3):e89974. PubMed ID: 24651645
[TBL] [Abstract][Full Text] [Related]
10. Assessing the cost-effectiveness of HPV vaccination strategies for adolescent girls and boys in the UK.
Datta S; Pink J; Medley GF; Petrou S; Staniszewska S; Underwood M; Sonnenberg P; Keeling MJ
BMC Infect Dis; 2019 Jun; 19(1):552. PubMed ID: 31234784
[TBL] [Abstract][Full Text] [Related]
11. No evidence for cross-protection of the HPV-16/18 vaccine against HPV-6/11 positivity in female STI clinic visitors.
Woestenberg PJ; King AJ; van der Sande MA; Donken R; Leussink S; van der Klis FR; Hoebe CJ; Bogaards JA; van Benthem BH; ;
J Infect; 2017 Apr; 74(4):393-400. PubMed ID: 28126492
[TBL] [Abstract][Full Text] [Related]
12. Efficacy, immunogenicity and safety of the AS04-HPV-16/18 vaccine in Chinese women aged 18-25 years: End-of-study results from a phase II/III, randomised, controlled trial.
Zhu FC; Hu SY; Hong Y; Hu YM; Zhang X; Zhang YJ; Pan QJ; Zhang WH; Zhao FH; Zhang CF; Yang X; Yu JX; Zhu J; Zhu Y; Chen F; Zhang Q; Wang H; Wang C; Bi J; Xue S; Shen L; Zhang YS; He Y; Tang H; Karkada N; Suryakiran P; Bi D; Struyf F
Cancer Med; 2019 Oct; 8(14):6195-6211. PubMed ID: 31305011
[TBL] [Abstract][Full Text] [Related]
13. Association between human papillomavirus vaccine status and sexually transmitted infection outcomes among females aged 18-35 with a history of sexual activity in the United States: A population survey-based cross-sectional analysis.
Closson K; Karim ME; Sadarangani M; Naus M; Ogilvie GS; Donken R
Vaccine; 2020 Dec; 38(52):8396-8404. PubMed ID: 33239227
[TBL] [Abstract][Full Text] [Related]
14. Human Papillomavirus (HPV) Prevalence in Male Adolescents 4 Years After HPV-16/18 Vaccination.
Lehtinen T; Söderlund-Strand A; Petäjä T; Eriksson T; Jokiranta S; Natunen K; Dillner J; Lehtinen M
J Infect Dis; 2017 Nov; 216(8):966-968. PubMed ID: 28968844
[TBL] [Abstract][Full Text] [Related]
15. Revisiting assumptions about age-based mixing representations in mathematical models of sexually transmitted infections.
Easterly CW; Alarid-Escudero F; Enns EA; Kulasingam S
Vaccine; 2018 Sep; 36(37):5572-5579. PubMed ID: 30093290
[TBL] [Abstract][Full Text] [Related]
16. Continuing reductions in HPV 16/18 in a population with high coverage of bivalent HPV vaccination in England: an ongoing cross-sectional study.
Mesher D; Panwar K; Thomas SL; Beddows S; Soldan K
BMJ Open; 2016 Feb; 6(2):e009915. PubMed ID: 26868944
[TBL] [Abstract][Full Text] [Related]
17. Optimal human papillomavirus vaccination strategies to prevent cervical cancer in low-income and middle-income countries in the context of limited resources: a mathematical modelling analysis.
Drolet M; Laprise JF; Martin D; Jit M; Bénard É; Gingras G; Boily MC; Alary M; Baussano I; Hutubessy R; Brisson M
Lancet Infect Dis; 2021 Nov; 21(11):1598-1610. PubMed ID: 34245682
[TBL] [Abstract][Full Text] [Related]
18. Attitudes, Knowledge and Factors Associated with Human Papillomavirus (HPV) Vaccine Uptake in Adolescent Girls and Young Women in Victoria, Australia.
Tung IL; Machalek DA; Garland SM
PLoS One; 2016; 11(8):e0161846. PubMed ID: 27564213
[TBL] [Abstract][Full Text] [Related]
19. Awareness and acceptance of human papillomavirus (HPV) vaccination among males attending a major sexual health clinic in Wuxi, China: A cross-sectional study.
Zou H; Meng X; Jia T; Zhu C; Chen X; Li X; Xu J; Ma W; Zhang X
Hum Vaccin Immunother; 2016 Jun; 12(6):1551-9. PubMed ID: 26467510
[TBL] [Abstract][Full Text] [Related]
20. [Human papillomavirus infection and vaccination].
He ZH; Kou ZQ; Xu AQ
Zhonghua Yu Fang Yi Xue Za Zhi; 2018 Jan; 52(1):106-112. PubMed ID: 29334719
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
